高级检索
    刘晓晴, 李锋. 晚期非鳞非小细胞肺癌一线诱导化疗后贝伐单抗联合培美曲塞维持治疗的疗效和安全性[J]. 循证医学, 2014, 14(1): 33-36. DOI: 10.3969/j.issn.1671-5144.2014.01.004
    引用本文: 刘晓晴, 李锋. 晚期非鳞非小细胞肺癌一线诱导化疗后贝伐单抗联合培美曲塞维持治疗的疗效和安全性[J]. 循证医学, 2014, 14(1): 33-36. DOI: 10.3969/j.issn.1671-5144.2014.01.004
    shu
    LIU Xiao-qing, LI Feng. Efficacy and Safety of Maintenance Bevacizumab Combined with Pemetrexed after First-Line Induction Chemotherapy in Advanced Nonsquamous Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2014, 14(1): 33-36. DOI: 10.3969/j.issn.1671-5144.2014.01.004
    Citation: LIU Xiao-qing, LI Feng. Efficacy and Safety of Maintenance Bevacizumab Combined with Pemetrexed after First-Line Induction Chemotherapy in Advanced Nonsquamous Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2014, 14(1): 33-36. DOI: 10.3969/j.issn.1671-5144.2014.01.004
    shu

    晚期非鳞非小细胞肺癌一线诱导化疗后贝伐单抗联合培美曲塞维持治疗的疗效和安全性

    Efficacy and Safety of Maintenance Bevacizumab Combined with Pemetrexed after First-Line Induction Chemotherapy in Advanced Nonsquamous Non-Small Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(4)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回